☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
94-3125814
|
|
(State or other jurisdiction of
incorporation or organization)
|
(IRS Employer
Identification No.)
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||
Common Stock ($0.001 par value)
|
IVAC
|
The Nasdaq Stock Market LLC (Nasdaq) Global Select
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☒
|
|||
Non-accelerated
filer
|
☐
|
Smaller reporting company
|
☒
|
|||
Emerging growth company
|
☐
|
No.
|
Page
|
|||||
Item 1.
|
Financial Statements (unaudited) | |||||
Condensed Consolidated Balance Sheets | 3 | |||||
Condensed Consolidated Statements of Operations | 4 | |||||
Condensed Consolidated Statements of Comprehensive Income (Loss) | 5 | |||||
Condensed Consolidated Statements of Cash Flows | 6 | |||||
Notes to Condensed Consolidated Financial Statements | 7 | |||||
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations | 22 | ||||
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk | 30 | ||||
Item 4.
|
Controls and Procedures | 30 | ||||
Item 1.
|
Legal Proceedings | 31 | ||||
Item 1A.
|
Risk Factors | 31 | ||||
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds | 37 | ||||
Item 3.
|
Defaults upon Senior Securities | 37 | ||||
Item 4.
|
Mine Safety Disclosures | 37 | ||||
Item 5.
|
Other Information | 38 | ||||
Item 6.
|
Exhibits | 38 | ||||
39 |
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
October 2,
2021
|
September 26,
2020
|
October 2,
2021
|
September 26,
2020
|
|||||||||||||
(Unaudited)
|
||||||||||||||||
(In thousands, except per share amounts)
|
||||||||||||||||
Net revenues:
|
||||||||||||||||
Systems and components
|
$ | 11,700 | $ | 15,027 | $ | 35,410 | $ | 51,589 | ||||||||
Technology development
|
3,093 | 6,538 | 9,437 | 17,659 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total net revenues
|
14,793 | 21,565 | 44,847 | 69,248 | ||||||||||||
Cost of net revenues:
|
||||||||||||||||
Systems and components
|
7,120 | 8,389 | 25,708 | 29,969 | ||||||||||||
Technology development
|
2,146 | 3,876 | 7,450 | 10,403 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cost of net revenues
|
9,266 | 12,265 | 33,158 | 40,372 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross profit
|
5,527 | 9,300 | 11,689 | 28,876 | ||||||||||||
Operating expenses:
|
||||||||||||||||
Research and development
|
3,743 | 3,603 | 11,262 | 10,594 | ||||||||||||
Selling, general and administrative
|
5,752 | 5,845 | 17,208 | 17,426 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total operating expenses
|
9,495 | 9,448 | 28,470 | 28,020 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income (loss) from operations
|
(3,968 | ) | (148 | ) | (16,781 | ) | 856 | |||||||||
Interest income and other income (expense), net
|
25 | 8 | 75 | 212 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income (loss) before provision for income taxes
|
(3,943 | ) | (140 | ) | (16,706 | ) | 1,068 | |||||||||
Provision for income taxes
|
290 | 217 | 157 | 1,125 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss
|
$ | (4,233 | ) | $ | (357 | ) | $ | (16,863 | ) | $ | (57 | ) | ||||
|
|
|
|
|
|
|
|
|||||||||
Net loss per share:
|
||||||||||||||||
Basic and Diluted
|
$ | (0.17 | ) | $ | (0.02 | ) | $ | (0.69 | ) | $ | (0.00 | ) | ||||
Weighted average common shares outstanding:
|
||||||||||||||||
Basic and Diluted
|
24,522 | 23,771 | 24,265 | 23,605 |
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
October 2,
2021
|
September 26,
2020
|
October 2,
2021
|
September 26,
2020
|
|||||||||||||
(Unaudited)
(In thousands)
|
||||||||||||||||
Net loss
|
$ | (4,233 | ) | $ | (357 | ) | $ | (16,863 | ) | $ | (57 | ) | ||||
|
|
|
|
|
|
|
|
|||||||||
Other comprehensive income (loss), before tax
|
||||||||||||||||
Change in unrealized net gain on
available-for-sale
|
(7 | ) | (24 | ) | (36 | ) | 29 | |||||||||
Foreign currency translation gains (losses)
|
(7 | ) | 124 | (47 | ) | 49 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Other comprehensive income (loss), before tax
|
(14 | ) | 100 | (83 | ) | 78 | ||||||||||
Income tax (expense) benefit related to items in other comprehensive income (loss)
|
— | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Other comprehensive income (loss), net of tax
|
(14 | ) | 100 | (83 | ) | 78 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Comprehensive income (loss)
|
$ | (4,247 | ) | $ | (257 | ) | $ | (16,946 | ) | $ | 21 | |||||
|
|
|
|
|
|
|
|
Nine months ended
|
||||||||
October 2,
2021
|
September 26,
2020
|
|||||||
(Unaudited)
(In thousands)
|
||||||||
Operating activities
|
||||||||
Net loss
|
$ | (16,863 | ) | $ | (57 | ) | ||
Adjustments to reconcile net loss to net cash and cash equivalents provided by (used in) operating activities:
|
||||||||
Depreciation and amortization
|
2,568 | 2,645 | ||||||
Net amortization (accretion) of investment premiums and discounts
|
88 | (9 | ) | |||||
Equity-based compensation
|
2,872 | 2,186 | ||||||
Straight-line rent adjustment and amortization of lease incentives
|
(350 | ) | (224 | ) | ||||
Deferred income taxes
|
(36 | ) | 516 | |||||
Changes in operating assets and liabilities
|
11,681 | 2,714 | ||||||
|
|
|
|
|||||
Total adjustments
|
16,823 | 7,828 | ||||||
|
|
|
|
|||||
Net cash and cash equivalents provided by (used in) operating activities
|
(40 | ) | 7,771 | |||||
Investing activities
|
||||||||
Purchases of investments
|
(13,214 | ) | (17,071 | ) | ||||
Proceeds from sales and maturities of investments
|
16,355 | 17,950 | ||||||
Purchases of leasehold improvements and equipment
|
(773 | ) | (2,329 | ) | ||||
|
|
|
|
|||||
Net cash and cash equivalents provided by (used in) investing activities
|
2,368 | (1,450 | ) | |||||
Financing activities
|
||||||||
Net proceeds from issuance of common stock
|
2,618 | 1,865 | ||||||
Common stock repurchases
|
— | (393 | ) | |||||
Taxes paid related to net share settlement
|
(545 | ) | (364 | ) | ||||
|
|
|
|
|||||
Net cash and cash equivalents provided by financing activities
|
2,073 | 1,108 | ||||||
Effect of exchange rate changes on cash
|
(47 | ) | 49 | |||||
|
|
|
|
|||||
Net increase in cash, cash equivalents and restricted cash
|
4,354 | 7,478 | ||||||
Cash, cash equivalents and restricted cash at beginning of period
|
30,128 | 20,554 | ||||||
|
|
|
|
|||||
Cash, cash equivalents and restricted cash at end of period
|
$ | 34,482 | $ | 28,032 | ||||
|
|
|
|
|||||
Non-cash
investing and financing activity
|
||||||||
Additions to
right-of-use-assets
|
$ | — | $ | 128 | ||||
|
|
|
|
1.
|
Description of Business and Basis of Presentation
|
2.
|
Revenue
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
TFE
|
Three Months Ended October 2, 2021
|
Three Months Ended September 26, 2020
|
||||||||||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||||||||||
HDD
|
DCP
|
PV
|
ASP
|
Total
|
HDD
|
PV
|
Total
|
|||||||||||||||||||||||||
Systems, upgrades and spare parts
|
$
|
6,495
|
|
$
|
—
|
|
$
|
61
|
|
$
|
—
|
|
$
|
6,556
|
|
$
|
7,601
|
|
$
|
131
|
|
$
|
7,732
|
|
||||||||
Field service
|
|
1,424
|
|
|
—
|
|
|
18
|
|
|
—
|
|
|
1,442
|
|
|
1,635
|
|
|
—
|
|
|
1,635
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total TFE net revenues
|
$
|
7,919
|
|
$
|
—
|
|
$
|
79
|
|
$
|
—
|
|
$
|
7,998
|
|
$
|
9,236
|
|
$
|
131
|
|
$
|
9,367
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended October 2, 2021
|
Nine Months Ended September 26, 2020
|
|||||||||||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||||||||||
HDD
|
DCP
|
PV
|
ASP
|
Total
|
HDD
|
PV
|
Total
|
|||||||||||||||||||||||||
Systems, upgrades and spare parts
|
$
|
14,034
|
|
$
|
3
|
|
$
|
219
|
|
$
|
3,850
|
|
$
|
18,106
|
|
$
|
29,189
|
|
$
|
400
|
|
$
|
29,589
|
|
||||||||
Field service
|
|
4,425
|
|
|
14
|
|
|
60
|
|
|
—
|
|
|
4,499
|
|
|
4,334
|
|
|
2
|
|
|
4,336
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total TFE net revenues
|
$
|
18,459
|
|
$
|
17
|
|
$
|
279
|
|
$
|
3,850
|
|
$
|
22,605
|
|
$
|
33,523
|
|
$
|
402
|
|
$
|
33,925
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
Photonics
|
October 2,
2021
|
September 26,
2020
|
October 2,
2021
|
September 26,
2020
|
||||||||||||
(In thousands)
|
||||||||||||||||
Products:
|
||||||||||||||||
Military products
|
$ | 3,343 | $ | 4,947 | $ | 11,552 | $ | 15,758 | ||||||||
Commercial products
|
100 | 139 | 278 | 257 | ||||||||||||
Repair and other services
|
259 | 574 | 975 | 1,649 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Photonics product net revenues
|
3,702 | 5,660 | 12,805 | 17,664 | ||||||||||||
Technology development:
|
||||||||||||||||
Firm Fixed Price (“FFP”)
|
1,571 | 5,482 | 4,919 | 15,374 | ||||||||||||
Cost Plus Fixed Fee (“CPFF”)
|
1,522 | 1,056 | 4,518 | 2,285 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total technology development net revenues
|
3,093 | 6,538 | 9,437 | 17,659 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Photonics net revenues
|
$ | 6,795 | $ | 12,198 | $ | 22,242 | $ | 35,323 | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Three Months Ended
|
Three Months Ended
|
|||||||||||||||||||||||
October 2, 2021
|
September 26, 2020
|
|||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
TFE
|
Photonics
|
Total
|
TFE
|
Photonics
|
Total
|
|||||||||||||||||||
United States
|
$
|
220
|
|
$
|
6,738
|
|
$
|
6,958
|
|
$
|
1,764
|
|
$
|
12,079
|
|
$
|
13,843
|
|
||||||
Asia
|
|
7,778
|
|
|
—
|
|
|
7,778
|
|
|
7,536
|
|
|
—
|
|
|
7,536
|
|
||||||
Europe
|
|
—
|
|
|
57
|
|
|
57
|
|
|
67
|
|
|
119
|
|
|
186
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total net revenues
|
$
|
7,998
|
|
$
|
6,795
|
|
$
|
14,793
|
|
$
|
9,367
|
|
$
|
12,198
|
|
$
|
21,565
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
|
Nine Months Ended
|
|||||||||||||||||||||||
October 2, 2021
|
September 26, 2020
|
|||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
TFE
|
Photonics
|
Total
|
TFE
|
Photonics
|
Total
|
|||||||||||||||||||
United States
|
$
|
2,708
|
|
$
|
22,069
|
|
$
|
24,777
|
|
$
|
2,596
|
|
$
|
35,060
|
|
$
|
37,656
|
|
||||||
Asia
|
|
16,047
|
|
|
—
|
|
|
16,047
|
|
|
31,262
|
|
|
—
|
|
|
31,262
|
|
||||||
Europe
|
|
3,850
|
|
|
173
|
|
|
4,023
|
|
|
67
|
|
|
263
|
|
|
330
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total net revenues
|
$
|
22,605
|
|
$
|
22,242
|
|
$
|
44,847
|
|
$
|
33,925
|
|
$
|
35,323
|
|
$
|
69,248
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
Three Months Ended
|
|||||||||||||||||||||||
October 2, 2021
|
September 26, 2020
|
|||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
TFE
|
Photonics
|
Total
|
TFE
|
Photonics
|
Total
|
|||||||||||||||||||
Products transferred at a point in time
|
$
|
7,998
|
|
$
|
259
|
|
$
|
8,257
|
|
$
|
9,367
|
|
$
|
574
|
|
$
|
9,941
|
|
||||||
Products and services transferred over time
|
|
—
|
|
|
6,536
|
|
|
6,536
|
|
|
—
|
|
|
11,624
|
|
|
11,624
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
$
|
7,998
|
|
$
|
6,795
|
|
$
|
14,793
|
|
$
|
9,367
|
|
$
|
12,198
|
|
$
|
21,565
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
|
Nine Months Ended
|
|||||||||||||||||||||||
October 2, 2021
|
September 26, 2020
|
|||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
TFE
|
Photonics
|
Total
|
TFE
|
Photonics
|
Total
|
|||||||||||||||||||
Products transferred at a point in time
|
$
|
22,605
|
|
$
|
574
|
|
$
|
23,179
|
|
$
|
33,925
|
|
$
|
1,649
|
|
$
|
35,574
|
|
||||||
Products and services transferred over time
|
|
—
|
|
|
21,668
|
|
|
21,668
|
|
|
—
|
|
|
33,674
|
|
|
33,674
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
$
|
22,605
|
|
$
|
22,242
|
|
$
|
44,847
|
|
$
|
33,925
|
|
$
|
35,323
|
|
$
|
69,248
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
October 2,
2021
|
January 2,
2021
|
Nine Months
Change
|
||||||||||
(In thousands)
|
||||||||||||
TFE:
|
||||||||||||
Contract assets:
|
||||||||||||
Accounts receivable, unbilled
|
$ | — | $ | 369 | $ | (369 | ) | |||||
|
|
|
|
|
|
|||||||
Contract liabilities:
|
||||||||||||
Deferred revenue
|
$ | 197 | $ | 482 | $ | (285 | ) | |||||
Customer advances
|
24 | 33 | (9 | ) | ||||||||
|
|
|
|
|
|
|||||||
$ | 221 | $ | 515 | $ | (294 | ) | ||||||
|
|
|
|
|
|
|||||||
Photonics:
|
||||||||||||
Contract assets:
|
||||||||||||
Accounts receivable, unbilled
|
$ | 1,493 | $ | 5,439 | $ | (3,946 | ) | |||||
Retainage
|
87 | 126 | (39 | ) | ||||||||
|
|
|
|
|
|
|||||||
$ | 1,580 | $ | 5,565 | $ | (3,985 | ) | ||||||
|
|
|
|
|
|
|||||||
Contract liabilities:
|
||||||||||||
Deferred revenue
|
$ | 550 | $ | 779 | $ | (229 | ) | |||||
|
|
|
|
|
|
3.
|
Inventories
|
October 2,
|
January 2,
|
|||||||
2021
|
2021
|
|||||||
(In thousands)
|
||||||||
Raw materials
|
$ | 11,262 | $ | 9,999 | ||||
Work-in-progress
|
6,929 | 4,832 | ||||||
Finished goods
|
4,262 | 6,858 | ||||||
|
|
|
|
|||||
$ | 22,453 | $ | 21,689 | |||||
|
|
|
|
4.
|
Equity-Based Compensation
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
October 2,
2021
|
September 26,
2020
|
October 2,
2021
|
September 26,
2020
|
|||||||||||||
(In thousands)
|
||||||||||||||||
Equity-based compensation by type of award:
|
||||||||||||||||
Stock options
|
$ | 27 | $ | 47 | $ | 159 | $ | 411 | ||||||||
RSUs
|
673 | 495 | 1,872 | 1,311 | ||||||||||||
ESPP awards
|
185 | 316 | 841 | 464 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total equity-based compensation
|
$ | 885 | $ | 858 | $ | 2,872 | $ | 2,186 | ||||||||
|
|
|
|
|
|
|
|
Shares
|
Weighted-Average
Exercise Price
|
|||||||
Options outstanding at January 2, 2021
|
1,814,467 | $ | 6.66 | |||||
Options granted
|
— | $ | — | |||||
Options cancelled and forfeited
|
(211,042 | ) | $ | 7.47 | ||||
Options exercised
|
(73,744 | ) | $ | 5.89 | ||||
|
|
|||||||
Options outstanding at October 2, 2021
|
1,529,681 | $ | 6.57 | |||||
|
|
|||||||
Options exercisable at October 2, 2021
|
1,317,356 | $ | 6.78 |
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
October 2,
2021 |
September 26,
2020 |
October 2,
2021 |
September 26,
2020 |
|||||||||||||
Stock Options:
|
||||||||||||||||
Weighted-average fair value of grants per share
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
1.82
|
|
||||
Expected volatility
|
|
—
|
|
|
—
|
|
|
—
|
|
|
46.04
|
%
|
||||
Risk-free interest rate
|
|
—
|
|
|
—
|
|
|
—
|
|
|
0.44
|
%
|
||||
Expected term of options (in years)
|
|
—
|
|
|
—
|
|
|
—
|
|
4.39
|
|
|||||
Dividend yield
|
|
—
|
|
|
—
|
|
|
—
|
|
|
None
|
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
October 2,
2021 |
September 26,
2020 |
October 2,
2021 |
September 26,
2020 |
|||||||||||||
Stock Purchase Rights:
|
||||||||||||||||
Weighted-average fair value of grants per share
|
$
|
2.43
|
|
$
|
2.20
|
|
$
|
2.59
|
|
$
|
2.20
|
|
||||
Expected volatility
|
|
64.94
|
%
|
|
51.72
|
%
|
|
60.88
|
%
|
|
51.49
|
%
|
||||
Risk-free interest rate
|
|
0.07
|
%
|
|
0.12
|
%
|
|
0.08
|
%
|
|
0.14
|
%
|
||||
Expected term of purchase rights (in years)
|
|
0.75
|
|
|
1.26
|
|
|
0.91
|
|
|
1.24
|
|
||||
Dividend yield
|
|
None
|
|
|
None
|
|
|
None
|
|
|
None
|
|
Shares
|
Weighted-Average
Grant Date
Fair Value
|
|||||||
Non-vested
RSUs at January 2, 2021
|
901,634 | $ | 5.30 | |||||
Granted
|
590,931 | $ | 6.18 | |||||
Vested
|
(301,305 | ) | $ | 6.07 | ||||
Cancelled and forfeited
|
(82,529 | ) | $ | 4.66 | ||||
|
|
|||||||
Non-vested
RSUs at October 2, 2021
|
1,108,731 | $ | 5.60 | |||||
|
|
Nine Months Ended
|
||||
October 2, 2021
|
||||
Weighted-average fair value of grants per share
|
$ | 7.65 | ||
Expected volatility
|
56.26 | % | ||
Risk-free interest rate
|
0.15 | % | ||
Dividend yield
|
None |
Nine Months Ended
|
||||
September 26, 2020
|
||||
Weighted-average fair value of grants per share
|
$ | 3.16 | ||
Expected volatility
|
46.7 | % | ||
Risk-free interest rate
|
0.25 | % | ||
Dividend yield
|
None |
5.
|
Warranty
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
October 2,
2021
|
September 26,
2020
|
October 2,
2021
|
September 26,
2020
|
|||||||||||||
(In thousands)
|
||||||||||||||||
Opening balance
|
$ | 572 | $ | 662 | $ | 480 | $ | 1,022 | ||||||||
Expenditures incurred under warranties
|
(148 | ) | (89 | ) | (564 | ) | (398 | ) | ||||||||
Accruals for product warranties issued during the reporting period
|
80 | 39 | 553 | 198 | ||||||||||||
Adjustments to previously existing warranty accruals
|
106 | (57 | ) | 141 | (267 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Closing balance
|
$ | 610 | $ | 555 | $ | 610 | $ | 555 | ||||||||
|
|
|
|
|
|
|
|
October 2,
2021
|
January 2,
2021
|
|||||||
(In thousands)
|
||||||||
Other accrued liabilities
|
$ | 542 | $ | 405 | ||||
Other long-term liabilities
|
68 | 75 | ||||||
|
|
|
|
|||||
Total warranty provision
|
$ | 610 | $ | 480 | ||||
|
|
|
|
6.
|
Guarantees
|
7.
|
Cash, Cash Equivalents and Investments
|
October 2, 2021
|
||||||||||||||||
Amortized Cost
|
Unrealized
Holding
Gains
|
Unrealized
Holding
Losses
|
Fair Value
|
|||||||||||||
(In thousands)
|
||||||||||||||||
Cash and cash equivalents:
|
||||||||||||||||
Cash
|
$ | 28,749 | $ | — | $ | — | $ | 28,749 | ||||||||
Money market funds
|
4,447 | — | — | 4,447 | ||||||||||||
Municipal bonds
|
500 | — | — | 500 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash and cash equivalents
|
$ | 33,696 | $ | — | $ | — | $ | 33,696 | ||||||||
Short-term investments:
|
||||||||||||||||
Certificates of deposit
|
$ | 6,299 | $ | 3 | $ | — | $ | 6,302 | ||||||||
Commercial paper
|
400 | — | — | 400 | ||||||||||||
Corporate bonds and medium-term notes
|
2,919 | 1 | — | 2,920 | ||||||||||||
Municipal bonds
|
515 | — | — | 515 | ||||||||||||
U.S. treasury and agency securities
|
1,000 | — | — | 1,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total short-term investments
|
$ | 11,133 | $ | 4 | $ | — | $ | 11,137 | ||||||||
Long-term investments:
|
||||||||||||||||
Asset backed securities
|
$ | 480 | $ | — | $ | — | $ | 480 | ||||||||
Certificates of deposit
|
500 | — | 1 | 499 | ||||||||||||
Corporate bonds and medium-term notes
|
2,541 | 1 | 1 | 2,541 | ||||||||||||
Municipal bonds
|
145 | — | 1 | 144 | ||||||||||||
U.S. treasury and agency securities
|
2,161 | — | — | 2,161 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total long-term investments
|
$ | 5,827 | $ | 1 | $ | 3 | $ | 5,825 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash, cash equivalents, and investments
|
$ | 50,656 | $ | 5 | $ | 3 | $ | 50,658 | ||||||||
|
|
|
|
|
|
|
|
January 2, 2021
|
||||||||||||||||
Amortized Cost
|
Unrealized
Holding Gains |
Unrealized
Holding Losses |
Fair Value
|
|||||||||||||
(In thousands)
|
||||||||||||||||
Cash and cash equivalents:
|
||||||||||||||||
Cash
|
$ | 24,729 | $ | — | $ | — | $ | 24,729 | ||||||||
Money market funds
|
3,612 | — | — | 3,612 | ||||||||||||
Certificates of deposit
|
1,000 | — | — | 1,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash and cash equivalents
|
$ | 29,341 | $ | — | $ | — | $ | 29,341 | ||||||||
Short-term investments:
|
||||||||||||||||
Certificates of deposit
|
$ | 6,450 | $ | 2 | $ | — | $ | 6,452 | ||||||||
Commercial paper
|
500 | — | — | 500 | ||||||||||||
Corporate bonds and medium-term notes
|
2,929 | 6 | — | 2,935 | ||||||||||||
Municipal bonds
|
400 | — | — | 400 | ||||||||||||
U.S. treasury and agency securities
|
4,527 | 25 | — | 4,552 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total short-term investments
|
$ | 14,806 | $ | 33 | $ | — | $ | 14,839 | ||||||||
Long-term investments:
|
||||||||||||||||
Certificates of deposit
|
$ | 500 | $ | — | $ | — | $ | 500 | ||||||||
Corporate bonds and medium-term notes
|
3,474 | 4 | — | 3,478 | ||||||||||||
U.S. treasury and agency securities
|
1,409 | 1 | — | 1,410 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total long-term investments
|
$ | 5,383 | $ | 5 | $ | — | $ | 5,388 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash, cash equivalents, and investments
|
$ | 49,530 | $ | 38 | $ | — | $ | 49,568 | ||||||||
|
|
|
|
|
|
|
|
October 2, 2021
|
||||||||
Amortized
Cost
|
Fair Value
|
|||||||
(In thousands)
|
||||||||
Due in one year or less
|
$ | 16,080 | $ | 16,084 | ||||
Due after one through three years
|
5,827 | 5,825 | ||||||
|
|
|
|
|||||
$ | 21,907 | $ | 21,909 | |||||
|
|
|
|
October 2, 2021
|
||||||||||||||||
In Loss Position for
Less than 12 Months
|
In Loss Position for
Greater than 12 Months
|
|||||||||||||||
Fair Value
|
Gross
Unrealized
Losses
|
Fair Value
|
Gross
Unrealized
Losses |
|||||||||||||
(In thousands)
|
||||||||||||||||
Certificates of deposit
|
$ | 499 | $ | 1 | $ | — | $ | — | ||||||||
Corporate bonds and medium-term notes
|
1,944 | 1 | — | — | ||||||||||||
Municipal bond
|
145 | 1 | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 2,588 | $ | 3 | $ | — | $ | — | |||||||||
|
|
|
|
|
|
|
|
Fair Value Measurements
at October 2, 2021
|
||||||||||||
Total
|
Level 1
|
Level 2
|
||||||||||
(In thousands)
|
||||||||||||
Recurring fair value measurements:
|
||||||||||||
Available-for-sale
|
||||||||||||
Money market funds
|
$ | 4,447 | $ | 4,447 | $ | — | ||||||
U.S. treasury and agency securities
|
3,161 | 3,161 | — | |||||||||
Asset backed securities
|
480 | — | 480 | |||||||||
Certificates of deposit
|
6,801 | — | 6,801 | |||||||||
Commercial paper
|
400 | — | 400 | |||||||||
Corporate bonds and medium-term notes
|
5,461 | — | 5,461 | |||||||||
Municipal bonds
|
1,159 | — | 1,159 | |||||||||
|
|
|
|
|
|
|||||||
Total recurring fair value measurements
|
$ | 21,909 | $ | 7,608 | $ | 14,301 | ||||||
|
|
|
|
|
|
8.
|
Derivative Instruments
|
(a) |
Other accrued liabilities
|
9.
|
Equity
|
Three months ended October 2, 2021
|
||||||||||||||||||||
Common
Stock and Additional
Paid-in
Capital |
Treasury
Stock |
Accumulated
Other Comprehensive Income |
Accumulated
Deficit |
Total
Stockholders’ Equity |
||||||||||||||||
Balance at July 3, 2021
|
$ | 196,088 | $ | (29,551 | ) | $ | 571 | $ | (75,360 | ) | $ | 91,748 | ||||||||
Common stock issued under employee plans
|
1,182 | — | — | — | 1,182 | |||||||||||||||
Shares withheld for net share settlement of RSUs
|
(13 | ) | — | — | — | (13 | ) | |||||||||||||
Equity-based compensation expense
|
885 | — | — | — | 885 | |||||||||||||||
Net loss
|
— | — | — | (4,233 | ) | (4,233 | ) | |||||||||||||
Other comprehensive loss
|
— | — | (14 | ) | — | (14 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance at October 2, 2021
|
$ | 198,142 | $ | (29,551 | ) | $ | 557 | $ | (79,593 | ) | $ | 89,555 | ||||||||
|
|
|
|
|
|
|
|
|
|
Nine months ended October 2, 2021
|
||||||||||||||||||||
Common
Stock and Additional
Paid-in
Capital |
Treasury
Stock |
Accumulated
Other Comprehensive Income |
Accumulated
Deficit |
Total
Stockholders’ Equity |
||||||||||||||||
Balance at January 2, 2021
|
$ | 193,197 | $ | (29,551 | ) | $ | 640 | $ | (62,730 | ) | $ | 101,556 | ||||||||
Common stock issued under employee plans
|
2,618 | — | — | — | 2,618 | |||||||||||||||
Shares withheld for net share settlement of RSUs
|
(545 | ) | — | — | — | (545 | ) | |||||||||||||
Equity-based compensation expense
|
2,872 | — | — | — | 2,872 | |||||||||||||||
Net loss
|
— | — | — | (16,863 | ) | (16,863 | ) | |||||||||||||
Other comprehensive loss
|
— | — | (83 | ) | — | (83 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance at October 2, 2021
|
$ | 198,142 | $ | (29,551 | ) | $ | 557 | $ | (79,593 | ) | $ | 89,555 | ||||||||
|
|
|
|
|
|
|
|
|
|
Three months ended September 26, 2020
|
||||||||||||||||||||
Common
Stock and Additional
Paid-in
Capital |
Treasury
Stock |
Accumulated
Other Comprehensive Income |
Accumulated
Deficit |
Total
Stockholders’ Equity |
||||||||||||||||
Balance at June 27, 2020
|
$ | 190,290 | $ | (29,551 | ) | $ | 402 | $ | (63,486 | ) | $ | 97,655 | ||||||||
Common stock issued under employee plans
|
871 | — | — | — | 871 | |||||||||||||||
Shares withheld for net share settlement of RSUs
|
(19 | ) | — | — | — | (19 | ) | |||||||||||||
Equity-based compensation expense
|
858 | — | — | — | 858 | |||||||||||||||
Net loss
|
— | — | — | (357 | ) | (357 | ) | |||||||||||||
Other comprehensive income
|
— | — | 100 | — | 100 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance at September 26, 2020
|
$ | 192,000 | $ | (29,551 | ) | $ | 502 | $ | (63,843 | ) | $ | 99,108 | ||||||||
|
|
|
|
|
|
|
|
|
|
Nine months ended September 26, 2020
|
||||||||||||||||||||
Common
Stock and Additional
Paid-in
Capital |
Treasury
Stock |
Accumulated
Other Comprehensive Income |
Accumulated
Deficit |
Total
Stockholders’ Equity |
||||||||||||||||
Balance at December 28, 2019
|
$ | 188,313 | $ | (29,158 | ) | $ | 424 | $ | (63,786 | ) | $ | 95,793 | ||||||||
Common stock issued under employee plans
|
1,865 | — | — | — | 1,865 | |||||||||||||||
Shares withheld for net share settlement of RSUs
|
(364 | ) | — | — | — | (364 | ) | |||||||||||||
Equity-based compensation expense
|
2,186 | — | — | — | 2,186 | |||||||||||||||
Net loss
|
— | — | — | (57 | ) | (57 | ) | |||||||||||||
Other comprehensive income
|
— | — | 78 | — | 78 | |||||||||||||||
Common stock repurchases
|
— | (393 | ) | — | — | (393 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance at September 26, 2020
|
$ | 192,000 | $ | (29,551 | ) | $ | 502 | $ | (63,843 | ) | $ | 99,108 | ||||||||
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||||||||||
October 2, 2021
|
||||||||||||||||||||||||
Foreign
currency
|
Unrealized
holding gains (losses) on
available-for-sale
investments |
Total
|
Foreign
currency |
Unrealized
holding gains (losses) on
available-for-sale
investments |
Total
|
|||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
Beginning balance
|
$ | 562 | $ | 9 | $ | 571 | $ | 602 | $ | 38 | $ | 640 | ||||||||||||
Other comprehensive loss before reclassification
|
(7 | ) | (7 | ) | (14 | ) | (47 | ) | (36 | ) | (83 | ) | ||||||||||||
Amounts reclassified from other comprehensive income (loss)
|
— | — | — | — | — | — | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net current-period other comprehensive loss
|
(7 | ) | (7 | ) | (14 | ) | (47 | ) | (36 | ) | (83 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Ending balance
|
$ | 555 | $ | 2 | $ | 557 | $ | 555 | $ | 2 | $ | 557 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||||||||||
September 26, 2020
|
||||||||||||||||||||||||
Foreign
currency
|
Unrealized
holding gains (losses) on
available-for-sale
investments |
Total
|
Foreign
currency |
Unrealized
holding gains on
available-for-sale
investments |
Total
|
|||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
Beginning balance
|
$ | 306 | $ | 96 | $ | 402 | $ | 381 | $ | 43 | $ | 424 | ||||||||||||
Other comprehensive income (loss) before reclassification
|
124 | (24 | ) | 100 | 49 | 29 | 78 | |||||||||||||||||
Amounts reclassified from other comprehensive income (loss)
|
— | — | — | — | — | — | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net current-period other comprehensive income
|
124 | (24 | ) | 100 | 49 | 29 | 78 | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Ending balance
|
$ | 430 | $ | 72 | $ | 502 | $ | 430 | $ | 72 | $ | 502 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
October 2,
2021
|
September 26,
2020
|
October 2,
2021
|
September 26,
2020
|
|||||||||||||
(In thousands, except per share amounts)
|
||||||||||||||||
Shares of common stock repurchased
|
— | — | — | 98 | ||||||||||||
Cost of stock repurchased
|
$ | — | $ | — | $ | — | $ | 393 | ||||||||
Average price paid per share
|
$ | — | $ | — | $ | — | $ | 3.97 |
10.
|
Net Loss Per Share
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
October 2,
2021
|
September 26,
2020
|
October 2,
2021
|
September 26,
2020
|
|||||||||||||
(In thousands, except per share amounts)
|
||||||||||||||||
Net loss
|
$ | (4,233 | ) | $ | (357 | ) | $ | (16,863 | ) | $ | (57 | ) | ||||
|
|
|
|
|
|
|
|
|||||||||
Weighted-average shares – basic
|
24,522 | 23,771 | 24,265 | 23,605 | ||||||||||||
Effect of dilutive potential common shares
|
— | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted-average shares – diluted
|
24,522 | 23,771 | 24,265 | 23,605 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss per share – basic
|
$ | (0.17 | ) | $ | (0.02 | ) | $ | (0.69 | ) | $ | (0.00 | ) | ||||
|
|
|
|
|
|
|
|
|||||||||
Net loss per share –diluted
|
$ | (0.17 | ) | $ | (0.02 | ) | $ | (0.69 | ) | $ | (0.00 | ) | ||||
|
|
|
|
|
|
|
|
11.
|
Segment Reporting
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
October 2,
2021
|
September 26,
2020
|
October 2,
2021
|
September 26,
2020
|
|||||||||||||
(In thousands)
|
||||||||||||||||
TFE
|
$ | 7,998 | $ | 9,367 | $ | 22,605 | $ | 33,925 | ||||||||
Photonics
|
6,795 | 12,198 | 22,242 | 35,323 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total segment net revenues
|
$ | 14,793 | $ | 21,565 | $ | 44,847 | $ | 69,248 | ||||||||
|
|
|
|
|
|
|
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
October 2,
2021
|
September 26,
2020
|
October 2,
2021
|
September 26,
2020
|
|||||||||||||
(In thousands)
|
||||||||||||||||
TFE
|
$ | (1,841 | ) | $ | (1,661 | ) | $ | (10,148 | ) | $ | (4,366 | ) | ||||
Photonics
|
(341 | ) | 3,032 | (1,742 | ) | 9,480 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total segment operating income (loss)
|
(2,182 | ) | 1,371 | (11,890 | ) | 5,114 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Unallocated costs
|
(1,786 | ) | (1,519 | ) | (4,891 | ) | (4,258 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Income (loss) from operations
|
(3,968 | ) | (148 | ) | (16,781 | ) | 856 | |||||||||
Interest income and other income (expense), net
|
25 | 8 | 75 | 212 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income (loss) before provision for income taxes
|
$ | (3,943 | ) | $ | (140 | ) | $ | (16,706 | ) | $ | 1,068 | |||||
|
|
|
|
|
|
|
|
October 2,
2021
|
January 2,
2021
|
|||||||
(In thousands)
|
||||||||
TFE
|
$ | 33,411 | $ | 44,335 | ||||
Photonics
|
16,810 | 22,923 | ||||||
|
|
|
|
|||||
Total segment assets
|
50,221 | 67,258 | ||||||
|
|
|
|
|||||
Cash, cash equivalents and investments
|
50,658 | 49,568 | ||||||
Restricted cash
|
786 | 787 | ||||||
Deferred income taxes
|
5,371 | 5,335 | ||||||
Other current assets
|
907 | 1,093 | ||||||
Common property, plant and equipment
|
1,100 | 1,443 | ||||||
Common operating lease
right-of-use
|
1,267 | 1,603 | ||||||
Other assets
|
183 | 151 | ||||||
|
|
|
|
|||||
Consolidated total assets
|
$ | 110,493 | $ | 127,238 | ||||
|
|
|
|
12.
|
Income Taxes
|
13.
|
Restructuring Charges
|
|
|
Three
Months Ended
October 2,
2021
|
|
|
Nine
Months Ended
October 2,
2021
|
|
|
Three and
Nine
Months
Ended September
26, 2020
|
|
|||
|
|
|
|
|
|
|
|
|
|
|||
|
|
(In thousands)
|
|
|||||||||
|
|
Severance and other employee-related costs
|
|
|||||||||
Beginning balance
|
$ | — | $ | — | $ | — | ||||||
Provision for restructuring reserves
|
276 | 319 | 103 | |||||||||
Cash payments made
|
(276 | ) | (319 | ) | (103 | ) | ||||||
|
|
|
|
|
|
|||||||
Ending balance
|
$ | — | $ | — | $ | — | ||||||
|
|
|
|
|
|
14.
|
Contingencies
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
Three months ended
|
Nine months ended
|
|||||||||||||||||||||||
October 2,
2021
|
September 26,
2020
|
Change over
prior period
|
October 2,
2021
|
September 26,
2020
|
Change over
prior period
|
|||||||||||||||||||
(In thousands, except percentages and per share amounts)
|
||||||||||||||||||||||||
Net revenues
|
$ | 14,793 | $ | 21,565 | $ | (6,772 | ) | $ | 44,847 | $ | 69,248 | $ | (24,401 | ) | ||||||||||
Gross profit
|
$ | 5,527 | $ | 9,300 | $ | (3,773 | ) | $ | 11,689 | $ | 28,876 | $ | (17,187 | ) | ||||||||||
Gross margin percent
|
37.4 | % | 43.1 | % | (5.7) points | 26.1 | % | 41.7 | % | (15.6)points | ||||||||||||||
Income (loss) from operations
|
$ | (3,968 | ) | $ | (148 | ) | $ | (3,820 | ) | $ | (16,781 | ) | $ | 856 | $ | (17,637 | ) | |||||||
Net loss
|
$ | (4,233 | ) | $ | (357 | ) | $ | (3,876 | ) | $ | (16,863 | ) | $ | (57 | ) | $ | (16,806 | ) | ||||||
Net loss per diluted share
|
$ | (0.17 | ) | $ | (0.02 | ) | $ | (0.15 | ) | $ | (0.69 | ) | $ | (0.00 | ) | $ | (0.69 | ) |
Three months ended
|
Nine months ended
|
|||||||||||||||||||||||
October 2,
2021 |
September 26,
2020 |
Change over
prior period
|
October 2,
2021 |
September 26,
2020 |
Change over
prior period
|
|||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
TFE
|
$ | 7,998 | $ | 9,367 | $ | (1,369 | ) | $ | 22,605 | $ | 33,925 | $ | (11,320 | ) | ||||||||||
Photonics:
|
||||||||||||||||||||||||
Contract R&D
|
3,093 | 6,538 | (3,445 | ) | 9,437 | 17,659 | (8,222 | ) | ||||||||||||||||
Products
|
3,702 | 5,660 | (1,958 | ) | 12,805 | 17,664 | (4,859 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
6,795 | 12,198 | (5,403 | ) | 22,242 | 35,323 | (13,081 | ) | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total net revenues
|
$ | 14,793 | $ | 21,565 | $ | (6,772 | ) | $ | 44,847 | $ | 69,248 | $ | (24,401 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
October 2,
2021
|
January 2,
2021
|
September 26,
2020
|
||||||||||
(In thousands)
|
||||||||||||
TFE
|
$ | 16,925 | $ | 5,623 | $ | 18,092 | ||||||
Photonics
|
27,942 | 41,317 | 45,159 | |||||||||
|
|
|
|
|
|
|||||||
Total backlog
|
$ | 44,867 | $ | 46,940 | $ | 63,251 | ||||||
|
|
|
|
|
|
Three Months Ended
|
Three Months Ended
|
|||||||||||||||||||||||
October 2, 2021
|
September 26, 2020
|
|||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
TFE
|
Photonics
|
Total
|
TFE
|
Photonics
|
Total
|
|||||||||||||||||||
United States
|
$
|
220
|
|
$
|
6,738
|
|
$
|
6,958
|
|
$
|
1,764
|
|
$
|
12,079
|
|
$
|
13,843
|
|
||||||
Asia
|
|
7,778
|
|
|
—
|
|
|
7,778
|
|
|
7,536
|
|
|
—
|
|
|
7,536
|
|
||||||
Europe
|
|
—
|
|
|
57
|
|
|
57
|
|
|
67
|
|
|
119
|
|
|
186
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total net revenues
|
$
|
7,998
|
|
$
|
6,795
|
|
$
|
14,793
|
|
$
|
9,367
|
|
$
|
12,198
|
|
$
|
21,565
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
|
Nine Months Ended
|
|||||||||||||||||||||||
October 2, 2021
|
September 26, 2020
|
|||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
TFE
|
Photonics
|
Total
|
TFE
|
Photonics
|
Total
|
|||||||||||||||||||
United States
|
$
|
2,708
|
|
$
|
22,069
|
|
$
|
24,777
|
|
$
|
2,596
|
|
$
|
35,060
|
|
$
|
37,656
|
|
||||||
Asia
|
|
16,047
|
|
|
—
|
|
|
16,047
|
|
|
31,262
|
|
|
—
|
|
|
31,262
|
|
||||||
Europe
|
|
3,850
|
|
|
173
|
|
|
4,023
|
|
|
67
|
|
|
263
|
|
|
330
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total net revenues
|
$
|
22,605
|
|
$
|
22,242
|
|
$
|
44,847
|
|
$
|
33,925
|
|
$
|
35,323
|
|
$
|
69,248
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
Nine months ended
|
|||||||||||||||||||||||
October 2,
2021
|
September 26,
2020
|
Change over
prior period
|
October 2,
2021
|
September 26,
2020
|
Change over
prior period
|
|||||||||||||||||||
(In thousands, except percentages)
|
||||||||||||||||||||||||
TFE gross profit
|
$ | 3,350 | $ | 4,075 | $ | (725 | ) | $ | 6,491 | $ | 13,622 | $ | (7,131 | ) | ||||||||||
% of TFE net revenues
|
41.9 | % | 43.5 | % | 28.7 | % | 40.2 | % | ||||||||||||||||
Photonics gross profit
|
$ | 2,177 | $ | 5,225 | $ | (3,048 | ) | $ | 5,198 | $ | 15,254 | $ | (10,056 | ) | ||||||||||
% of Photonics net revenues
|
32.0 | % | 42.8 | % | 23.4 | % | 43.2 | % | ||||||||||||||||
Total gross profit
|
$ | 5,527 | $ | 9,300 | $ | (3,773 | ) | $ | 11,689 | $ | 28,876 | $ | (17,187 | ) | ||||||||||
% of net revenues
|
37.4 | % | 43.1 | % | 26.1 | % | 41.7 | % |
Three months ended
|
Nine months ended
|
|||||||||||||||||||||||
October 2,
2021
|
September 26,
2020
|
Change over
prior period
|
October 2,
2021
|
September 26,
2020
|
Change over
prior period
|
|||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
Research and development expense
|
$ | 3,743 | $ | 3,603 | $ | 140 | $ | 11,262 | $ | 10,594 | $ | 668 |
Three months ended
|
Nine months ended
|
|||||||||||||||||||||||
October 2,
2021
|
September 26,
2020
|
Change over
prior period
|
October 2,
2021
|
September 26,
2020
|
Change over
prior period
|
|||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
Selling, general and administrative expense
|
$ | 5,752 | $ | 5,845 | $ | (93 | ) | $ | 17,208 | $ | 17,426 | $ | (218 | ) |
Three months ended
|
Nine months ended
|
|||||||||||||||||||||||
October 2,
2021
|
September 26,
2020
|
Change over
prior period
|
October 2,
2021
|
September 26,
2020
|
Change over
prior period
|
|||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
Interest income and other income (expense), net
|
$ | 25 | $ | 8 | $ | 17 | $ | 75 | $ | 212 | $ | (137 | ) |
Three months ended
|
Nine months ended
|
|||||||||||||||||||||||
October 2,
2021
|
September 26,
2020
|
Change over
prior period
|
October 2,
2021
|
September 26,
2020
|
Change over
prior period
|
|||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
Provision for income taxes
|
$ | 290 | $ | 217 | $ | 73 | $ | 157 | $ | 1,125 | $ | (968 | ) |
October 2,
2021
|
January 2,
2021
|
|||||||
(In thousands)
|
||||||||
Cash and cash equivalents
|
$ | 33,696 | $ | 29,341 | ||||
Restricted cash
|
786 | 787 | ||||||
Short-term investments
|
11,137 | 14,839 | ||||||
Long-term investments
|
5,825 | 5,388 | ||||||
|
|
|
|
|||||
Total cash, cash equivalents, restricted cash and investments
|
$ | 51,444 | $ | 50,355 | ||||
|
|
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
Item 4.
|
Controls and Procedures
|
Item 1.
|
Legal Proceedings
|
Item 1A.
|
Risk Factors
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
Item 3.
|
Defaults upon Senior Securities
|
Item 4.
|
Mine Safety Disclosures
|
Item 5.
|
Other Information
|
Item 6.
|
Exhibits
|
Exhibit
Number |
Description
|
|
31.1 | Certification of President and Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
31.2 | Certification of Executive Vice President, Finance and Administration, Chief Financial Officer and Treasurer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
32.1 | Certifications Pursuant to U.S.C. 1350 Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.* | |
101 |
The following financial statements from the Registrant’s Quarterly Report on Form
10-Q
for the quarter ended October 2, 2021, formatted in Inline XBRL (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Comprehensive Income (Loss), (iv) Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements.
|
|
104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
* |
The certification attached as Exhibit 32.1 is deemed “furnished” and not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 and is not to be incorporated by reference into any filing of Intevac, Inc. under the Securities Exchange Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof, irrespective of any general incorporation by reference language contained in any such filing, except to the extent that the registrant specifically incorporates it by reference.
|
INTEVAC, INC.
|
||||||
Date: November 2, 2021
|
||||||
By:
|
/s/ WENDELL BLONIGAN
|
|||||
Wendell Blonigan
|
||||||
President, Chief Executive Officer and Director
|
||||||
(Principal Executive Officer)
|
||||||
Date: November 2, 2021
|
||||||
By:
|
/s/ JAMES MONIZ
|
|||||
James Moniz
|
||||||
Executive Vice President, Finance and Administration,
|
||||||
Chief Financial Officer, Secretary and Treasurer
|
||||||
(Principal Financial and Accounting Officer)
|
Exhibit 31.1
I, Wendell Blonigan certify that:
1. |
I have reviewed this Quarterly Report on Form 10-Q of Intevac, Inc.; |
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. |
The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. |
The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: November 2, 2021
/s/ WENDELL BLONIGAN |
Wendell Blonigan |
President, Chief Executive Officer and Director |
Exhibit 31.2
I, James Moniz certify that:
1. |
I have reviewed this Quarterly Report on Form 10-Q of Intevac, Inc.; |
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. |
The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. |
The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: November 2, 2021
/s/ JAMES MONIZ |
James Moniz |
Executive Vice President, Finance and Administration, |
Chief Financial Officer, Secretary and Treasurer |
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Wendell Blonigan, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Intevac, Inc. on Form 10-Q for the quarterly period ended October 2, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Intevac, Inc.
Date: November 2, 2021
/s/ WENDELL BLONIGAN |
Wendell Blonigan |
President, Chief Executive Officer and Director |
I, James Moniz, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Intevac, Inc. on Form 10-Q for the quarterly period ended October 2, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Intevac, Inc.
Date: November 2, 2021
/s/ JAMES MONIZ |
James Moniz |
Executive Vice President, Finance and Administration, |
Chief Financial Officer, Secretary and Treasurer |
A signed original of this written statement required by Section 906 has been provided to Intevac, Inc. and will be retained by Intevac, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
This certification accompanies the report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Intevac, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.